The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  November 2017 Next

Call for Nominations EFMC 2018 Awards

To acknowledge outstanding achievements in the field of Medicinal Chemistry, EFMC is conferring every two years three Awards on the occasion of the International Symposium on Medicinal Chemistry. The 2018 Awards will be conferred on the occasion of the XXV EFMC "International Symposium on Medicinal Chemistry" (EFMC-ISMC) to be held in Ljubljana, Slovenia on September 2-6, 2018.

All 3 awards consist of a diploma, € 7.500 and an invitation for a lecture by the Award recipient at the upcoming EFMC-ISMC International Symposium on Medicinal Chemistry.

The EFMC-Awards include:

For the advancement of Medicinal Chemistry and the development of international organizational structures in Medicinal Chemistry. The award will be given for outstanding achievements in the field of Medicinal Chemistry.

 To acknowledge and recognise outstanding research in the field of Medicinal Chemistry in its broadest sense by a young scientist. This Award has been established with the support of UCB Pharma.

To encourage innovation and investigation in technological development related to drug discovery, this Award established with the support of Prous Institute will be given for the discovery, evaluation or use of new technologies.

Nominations for these Awards consist of a nomination letter, a brief CV including a list of selected publications and two supporting letters. Self-nominations are also accepted. The nominations should be submitted to Dr Yves Auberson, President of the EFMC as of 2018, via the following link:

Deadline for submission: January 31, 2018


Laureates 2016

The EFMC is pleased to announce the recipients of the 2016 Awards:

Nauta Award for Pharmacochemistry
Prof. François Diederich – ETH Zürich, Switzerland

For his outstanding contributions to the science of medicinal chemistry. Prof. François Diederich made essential contributions to the fundamental understanding of non-bonding interactions involved in molecular recognition and their application in modern drug design. His scientific work is documented in more than 700 publications and beautifully describes interactions such as sulfur-aromatics, cation-Pi, fluorine interactions and halogen bonding that are actively used by many scientists around the world in the discovery of novel drugs.

UCB-Ehrlich Award for Excellence in Medicinal Chemistry
Prof. Paul J. Hergenrother – University of Illinois at Urbana-Champaign, United States

For his groundbreaking work on procaspase-3 activation by a small molecule PAC-1, thereby inducing apoptosis in cancer cells. In his scientific research he uses natural products as starting points for complex molecule synthesis in an approach named “complexity-to-diversity”.  Next to basic research, he also aims to bring his novel compounds to the clinic for the benefit of patients.

Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery
Prof. Jan Steyaert – VIB & VU Brussels, Belgium

For his pioneering work in the field of nanobody-enabled structural biology. His nanobody technology led to X-ray crystallographic structures of GPCRs locked in an agonist-bound active conformational state and to the first view of a GPCR transmembrane signalling complex. These novel GPCR structures are now finding widespread use in the discovery of novel drugs.

The Awards will be presented during the XXIV International Symposium on Medicinal Chemistry (EFMC-ISMC 2016), scheduled to be held on August 28 – September 1, 2016 in Manchester, United Kingdom.

Photographer - Fabien Venturi
Contact: venturifab@yahoo.fr


Previous Laureates

Nauta Award for Pharmacochemistry
2014: Dr Paul Leeson, GlaxoSmithKline, United Kingdom
2012: Prof. Alexander Levitzki, THe Hebrew University of Jerusalem, Israel
2010: Prof. Camille George Wermuth, University Louis Pasteur Strasbourg and Prestwick Chemicals

UCB-Ehrlich Award for Excellence in Medicinal Chemistry
2014: Prof. Craig Crews, Yale University, Department of Chemistry, New Haven, USA
2012: Dr Krzysztof Józwiak, Department of Chemistry, Medical University of Lublin, Poland
2010: Dr Anthony Wood, Pfizer Global Research and Development

Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery
2014: Prof. György Ferenczy and Prof. György Keseru, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary
2012: Dr Harren Jhoti, Astex Pharmaceuticals, UK
2010: Prof. Klaus Müller, ETH Zürich, Switzerland




EFMC Awards at EFMC-ISMC 2016

The 2016 EFMC Awards have been conferred on occasion of the XXIV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC), held in Manchester on August 28 - September 1, 2016.

Nauta Award for Pharmacochemistry
Prof. François Diederich – ETH Zürich, Switzerland

For his outstanding contributions to the science of medicinal chemistry. Prof. François Diederich made essential contributions to the fundamental understanding of non-bonding interactions involved in molecular recognition and their application in modern drug design. His scientific work is documented in more than 700 publications and beautifully describes interactions such as sulfur-aromatics, cation-Pi, fluorine interactions and halogen bonding that are actively used by many scientists around the world in the discovery of novel drugs.

UCB-Ehrlich Award for Excellence in Medicinal Chemistry
Prof. Paul J. Hergenrother – University of Illinois at Urbana-Champaign, United States

For his groundbreaking work on procaspase-3 activation by a small molecule PAC-1, thereby inducing apoptosis in cancer cells. In his scientific research he uses natural products as starting points for complex molecule synthesis in an approach named “complexity-to-diversity”.  Next to basic research, he also aims to bring his novel compounds to the clinic for the benefit of patients.

Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery
Prof. Jan Steyaert – VIB & VU Brussels, Belgium

For his pioneering work in the field of nanobody-enabled structural biology. His nanobody technology led to X-ray crystallographic structures of GPCRs locked in an agonist-bound active conformational state and to the first view of a GPCR transmembrane signalling complex. These novel GPCR structures are now finding widespread use in the discovery of novel drugs.

Photographer - Fabien Venturi
Contact: venturifab@yahoo.fr


M T W T F S S
30 31 01 02 03 04 05
06 07 08 09 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 01 02 03
All events   |  Future events

Job portal

15/11/2017
Early Stage Researcher in Medicinal Chemistry, University of Basel (UNIBAS), University of Utrecht (UU), PamGene: Department of Pharmaceutical Sciences (UNIBAS), Department of Chemical Biology & Drug Discovery (UU), Basel, Utrecht, 's-Hertogenbosch, Switzerland
read more


15/11/2017
Early Stage Researcher in Medicinal Chemistry, Lund University (ULUND), University of Basel (UNIBAS), RedGlead: Department of Chemistry (ULUND), Department of Pharmaceutical Sciences (UNIBAS), Lund, Basel, Sweden
read more


15/11/2017
Early Stage Researcher in Medicinal Chemistry, Faculty of Pharmacy, University of Ljubljana (UL), University of Utrecht (UU), PamGene: Chair of Pharmaceutical Chemistry (UL), Department of Chemical Biology & Drug Discovery (UU), Ljubljana, Utrecht, 's-Hertogenbosch, Slovenia
read more


15/11/2017
Early Stage Researcher in Medicinal Chemistry, University of Utrecht (UU), University of Ljubljana (UL), PamGene: Department of Chemical Biology & Drug Discovery (UU), Faculty of Pharmacy, Chair of Pharmaceutical Chemistry (UL), Utrecht, Ljubljana, 's-Hertogenbosch, The Netherlands
read more


15/11/2017
Early Stage Researcher in Medicinal Chemistry, University of Basel (UNIBAS), University of Ljubljana (UL), Glycopedia: Department of Pharmaceutical Sciences (UNIBAS), Faculty of Pharmacy, Chair of Pharmaceutical Chemistry (UL), Basel, Ljubljana, Grenoble, Switzerland
read more


15/11/2017
Early Stage Researcher in Medicinal Chemistry, Faculty of Pharmacy, University of Ljubljana (UL), Lund University (ULUND), SARomics, RedGlead: Chair of Pharmaceutical Chemistry (UL), Department of Chemistry (ULUND), Ljubljana, Lund, Slovenia
read more


15/11/2017
Early Stage Researcher in Medicinal Chemistry, Lund University (ULUND), Faculty of Pharmacy, University of Ljubljana (UL), SARomics: Department of Chemistry (ULUND), Chair of Pharmaceutical Chemistry (UL), Lund, Ljubljana, Sweden
read more


15/11/2017
Early Stage Researcher in Medicinal Chemistry, Università degli Studi di Milano (UMIL), Universiteit Utrecht (UU), PamGene: Department of Chemistry (UMIL), Department of Chemical Biology & Drug Discovery (UU), Milano, Utrecht, 's-Hertogenbosch, Italy
read more


15/11/2017
Early Stage Researcher in Medicinal Chemistry, Université Grenoble Alpes (UGA), Universiteit Utrecht (UU), PamGene: CERMAV (UGA), Department of Chemical Biology & Drug Discovery (UU), Gières, Utrecht, 's-Hertogenbosch, France
read more


15/11/2017
Early Stage Researcher in Medicinal Chemistry, University of Utrecht (UU), Université Grenoble Alpes (UGA), Glycopedia: Department of Chemical Biology & Drug Discovery (UU), CERMAV (UGA), Utrecht, Gières, Grenoble, The Netherlands
read more


15/11/2017
Early Stage Researcher in Medicinal Chemistry, Università degli Studi di Milano (UMIL), Université Grenoble Alpes (UGA), Glycopedia: Department of Chemistry (UMIL), CERMAV (UGA), Milano, Gières, Grenoble, Italy
read more


15/11/2017
Early Stage Researcher in Medicinal Chemistry, Université Grenoble Alpes (UGA), Università degli Studi di Milano (UMIL), Glycopedia: CERMAV (UGA), Department of Chemistry (UMIL), Gières, Milano, Grenoble, France
read more


15/09/2017
Research / Senior Scientist Medicinal Chemistry, UCB: Medicinal Chemistry, Braine - L'Alleud, Belgium
read more


15/09/2017
Principal Scientist Medicinal Chemistry, UCB: Medicinal Chemistry, Braine-L'Alleud, Belgium
read more


20/04/2017
Medicinal / Synthetic Organic Chemists, Concept Life Sciences: Drug Discovery, Sandwich, Kent, United Kingdom
read more


Job portal page

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRoche
 Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerck